Feedback / Questions
CID-078 - Circle Pharma
https://www.businesswire.com/news/home/20250616163110/en/Circle-Pharma-Receives-FDA-Orphan-Drug-Designation-for-CID-078-for-the-Treatment-of-Small-Cell-Lung-Cancer
Jun 16, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next